Stability of Ala 125 recombinant human interleukin-2 in solution

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 1, 2005, Pages 31-37

  Reyes, Nuria ^a   Ruiz, Llamil ^a   Aroche, Kethia ^a   Gerónimo, Haydee ^a   Brito, Olga ^a   Hardy, Eugenio ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ANTIOXIDANT; CYSTEINE; DRUG VEHICLE; EDETATE DISODIUM; EXCIPIENT; GLUTAMINE; GLYCINE; HISTIDINE; METHIONINE; POLYSORBATE 80; RECOMBINANT INTERLEUKIN 2;

ADSORPTION; AMINO ACID SUBSTITUTION; ARTICLE; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG DESIGN; DRUG STABILITY; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREFORMULATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACIDS; ANIMALS; ANTIOXIDANTS; CELL LINE; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXCIPIENTS; HUMANS; INTERLEUKIN-2; KINETICS; MICE; PHARMACEUTICAL SOLUTIONS; POLYSORBATES; RECOMBINANT PROTEINS;

EID: 11144304510     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055182     Document Type: Article

References (25)

1. Andersson, M. M., Breccia, J. D., Hatti-Kaul, R. (2000) Stabilizing effect of chemical additives against oxidation of lactate dehydrogenase. Biotechnol. Appl. Biochem. 32: 145-153
2. Bam, N. B., Randolph, T. W., Cleland, J. L. (1995) Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm. Res. 12: 2-11
3. Bergmann, C. A., Landmeier, B. J., Kaplan, D. R. (1991) Phase separation analysis of recombinant interleukin 2. Mol. Immunol. 28: 99-105
4. Chen, B. L., Arakawa, T., Hsu, E., Narhi, L. O., Tressel, T. J., Chien, S. L. (1994) Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. J. Pharm. Sci. 83: 1657-1661
5. Chun, T. W., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M., Park, S., Davey, R. T., Dybul, M., Kovacs, J. A., Metcalf, J. A., Mican, J. M., Berrey, M. M., Corey, L., Lane, H. C., Fauci, A. S. (1999) Effect of IL-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5: 651-655
6. Gillis, S., Ferm, M. M., Ou, W., Smith, K. A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120: 2027-2032
7. Ha, E., Wang, W., Wang, Y. J. (2002) Peroxide formation in polysorbate 80 and protein stability. J. Pharm. Sci. 91: 2252-2264
8. Herman, A. C., Boone, T. C., Lu, H. S. (1996) Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. Pharm. Biotechnol. 9: 303-328
9. Johnston, T. P. (1996) Adsorption of recombinant human granulocyte colony stimulating factor (rhG-CSF) to polyvinyl chloride, polypropylene, and glass: effect of solvent additives. PDA J. Pharm. Sci. Technol. 50: 238-245
10. Knepp, V. M., Whatley, J. L., Muchnik, A., Calderwood, T. S. (1996) Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor. PDA J. Pharm. Sci. Technol. 50: 163-171
11. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
12. Levine, R. L., Mosoni, L., Berlett, B. S., Stadtman, E. R. (1996) Methionine residues as endogenous antioxidants in proteins. Proc. Natl Acad. Sci. 93: 15036-15040
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275
14. Mark, D. F., Lin, L. S., Lu, S. Y. (1985) Human recombinant interleukin-2 muteins. United States Patent 4,518,584
15. Morgan, D. A., Ruscetti, F. W., Gallo, R. (1976) Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 193: 1007-1008
16. Moya, G., Gonzalez, L. J., Huerta, V., Garcia, Y., Morera, V., Perez, D., Brena, F., Arana, M. (2002) Isolation and characterization of modified species of a mutated (Cys125 -Ala) recombinant human interleukin-2. J. Chromatogr. A. 971: 129-142
17. Rodríguez, A., Fernandez, O., Guerra, M., Apezteguia, I., Moya, G., Perez, D., Breña, F., Agraz, A., Araña, M. (2001) Scale-up purification of a mutant of recombinant human Interleukin 2 by reverse-phase high performance liquid chromatography. Biotecnologĩa Aplicada 18: 159-162
18. Rosemberg, S. A., Mule, J. J., Spiess, P. J., Reichert, C. M., Schwarz, S. L. (1985) Regression of established pulmonary metastasis and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. J. Exp. Med. 161: 1169-1188
19. Sebeka, H. K., Starkuviene, B., Trepsiene, O. V., Pauliukonis, A. A., Bumelis, V. A. (2001) Comparative effects of stabilizing additives on the rates of heat inactivation of recombinant human interferon alpha-2b in solution. Antiviral Res. 50: 117-127
20. Sigarroa, A. (1985) Biometry and experimental design. Pueblo y Education, La Habana, pp 383-395
21. Smith, K. A. (1984) Interleukin 2. Annu. Rev. Immunol. 2: 319-333
22. Tada, H., Shiho, O., Kiroshima, K., Koyama, K., Tsukamoto, K. (1986) An improved colorimetric assay for interleukin-2. J. Immunol. Methods 93: 157-165
23. Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., Hamuro, J. (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302: 305-310
24. Tzannis, S. T., Hrushesky, W. J., Wood, P. A., Przybycien, T. M. (1997) Adsorption of a formulated protein on a drug delivery device surface. J. Colloid Interface Sci. 189: 216-228
25. Wang, W. (1999) Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185: 129-188